Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Conivaptan

A vasopressin V1a and V2 receptor antagonist given intravenously, approved in the United States in 2005 to correct low blood sodium levels (hyponatraemia) in hospitalised patients. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It was the first vasopressin antagonist approved in the United States: instead of making the body lose salts like classic diuretics, it makes it excrete only free water, an effect called aquaresis.

Conivaptan HClGo to the active ingredient →
Conivaptan-d4Isotopically labelledConivaptan-d4Cat. No. P-C246-002CAS 1129433-63-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.